Chung‐Pin Li
National Yang Ming Chiao Tung University(TW)Kaohsiung Medical University(TW)Kaohsiung Medical University Chung-Ho Memorial Hospital(TW)Taipei Veterans General Hospital(TW)
Publications by Year
Research Areas
Pancreatic and Hepatic Oncology Research, Neuroendocrine Tumor Research Advances, Cholangiocarcinoma and Gallbladder Cancer Studies, Hepatocellular Carcinoma Treatment and Prognosis, Cancer Genomics and Diagnostics
Most-Cited Works
- → Nanoliposomal irinotecan with fluorouracil and folinic acid in metastatic pancreatic cancer after previous gemcitabine-based therapy (NAPOLI-1): a global, randomised, open-label, phase 3 trial(2015)1,174 cited
- → Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma(2020)416 cited
- → A randomised, double-blind, placebo-controlled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas(2014)357 cited
- → Concurrent chemoradiotherapy treatment of locally advanced pancreatic cancer: Gemcitabine versus 5-fluorouracil, a randomized controlled study(2003)210 cited
- → High Blood Pressure and All-Cause and Cardiovascular Disease Mortalities in Community-Dwelling Older Adults(2015)204 cited